CannaPharmaRX, Inc. (CPMD)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0002 (-6.25%)
Aug 22, 2025, 2:33 PM EDT

CannaPharmaRX Statistics

Total Valuation

CannaPharmaRX has a market cap or net worth of 1.97 million. The enterprise value is 20.40 million.

Market Cap1.97M
Enterprise Value 20.40M

Important Dates

The last earnings date was Friday, August 15, 2025.

Earnings Date Aug 15, 2025
Ex-Dividend Date n/a

Share Statistics

CannaPharmaRX has 656.27 million shares outstanding. The number of shares has increased by 45.39% in one year.

Current Share Class 656.27M
Shares Outstanding 656.27M
Shares Change (YoY) +45.39%
Shares Change (QoQ) n/a
Owned by Insiders (%) 3.81%
Owned by Institutions (%) n/a
Float 607.90M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.45
PB Ratio -0.09
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.61
EV / Sales 14.99
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio 0.04
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.56

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -18.77%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 19.91%
Revenue Per Employee 52,355
Profits Per Employee -217,557
Employee Count26
Asset Turnover 0.12
Inventory Turnover 3.99

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -69.52% in the last 52 weeks. The beta is -1,571.44, so CannaPharmaRX's price volatility has been lower than the market average.

Beta (5Y) -1,571.44
52-Week Price Change -69.52%
50-Day Moving Average 0.00
200-Day Moving Average 0.01
Relative Strength Index (RSI) 52.45
Average Volume (20 Days) 107,968

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.00

Income Statement

In the last 12 months, CannaPharmaRX had revenue of 1.36 million and -5.66 million in losses. Loss per share was -0.01.

Revenue1.36M
Gross Profit -3.19M
Operating Income -3.48M
Pretax Income -5.66M
Net Income -5.66M
EBITDA -3.44M
EBIT -3.48M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 16,975 in cash and 17.82 million in debt, giving a net cash position of -17.80 million or -0.03 per share.

Cash & Cash Equivalents 16,975
Total Debt 17.82M
Net Cash -17.80M
Net Cash Per Share -0.03
Equity (Book Value) -22.57M
Book Value Per Share -0.04
Working Capital -27.76M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.77M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin -234.54%
Operating Margin -255.73%
Pretax Margin -415.54%
Profit Margin n/a
EBITDA Margin -252.75%
EBIT Margin -255.73%
FCF Margin n/a

Dividends & Yields

CannaPharmaRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -45.39%
Shareholder Yield n/a
Earnings Yield -287.30%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CannaPharmaRX has an Altman Z-Score of -16.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -16.3
Piotroski F-Score 3